Mifamurtide

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Key facts

Mifamurtide is a drug catalogued in DrugCentral. It was first approved by the EMA in 2009. DrugCentral lists 1 molecular target, including NOD2. Recorded indications include Osteosarcoma of bone.

• Molecular targets: NOD2 (1 listed in DrugCentral).
• Indications: Osteosarcoma of bone.
• ATC code: L03AX15 (Other immunostimulants).
• Molecular formula: C59H109N6O19P; molecular weight 1237.52 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Osteosarcoma of bone

Mechanism & targets

Molecular targets (1)

Target	Gene	Action	Activity
Nucleotide-binding oligomerization domain-containing protein 2	NOD2	activator	—

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
2009-03-06	EMA	—	Takeda France SAS	Yes

ATC classification

ATC code	Therapeutic hierarchy
L03AX15	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › IMMUNOSTIMULANTS › IMMUNOSTIMULANTS › Other immunostimulants

Chemical structure

• Molecular formula: C₅₉H₁₀₉N₆O₁₉P
• Molecular weight: 1237.52 g/mol
• CAS number: 90825-43-7
• InChIKey: JMUHBNWAORSSBD-WKYWBUFDSA-N
• PubChem CID: 123133557

CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCNC(=O)[C@H](C)NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)OC(=O)CCCCCCCCCCCCCCC

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Mifamurtide used for?

DrugCentral lists the following indications for Mifamurtide: Osteosarcoma of bone.

How does Mifamurtide work?

Its molecular targets in DrugCentral include NOD2 (activator).

When was Mifamurtide first approved?

Mifamurtide was first approved by the EMA in 2009.

What is the chemical formula of Mifamurtide?

Mifamurtide has the molecular formula C59H109N6O19P and a molecular weight of 1237.52 g/mol.

Sources

• DrugCentral drug card 2960 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL2107354 — compound record and bioactivity
• PubChem CID 123133557 — chemical identifiers
• DrugBank DB13615 — drug record
• FDA UNII 1LM890Q4FY — substance identity
• UniProt Q9HC29 (NOD2) — target protein

How this page is built: methodology · editorial policy & corrections.